Mimicking Retinoblastoma Treatment With Repeated Topotecan or Melphalan Develops Cross-Resistance to Classic Agents But Not to Repurposed Drugs.
Cancela MB, Winter U, Zugbi S, Dinardi M, Alves da Quinta D, Aschero R, Ganiewich D, Sampor C, Sgroi M, Lagomarsino E, Fandiño A, Llera AS, Chantada G, Carcaboso AM, Schaiquevich P.
Cancela MB, et al. Among authors: chantada g.
Invest Ophthalmol Vis Sci. 2024 Dec 2;65(14):14. doi: 10.1167/iovs.65.14.14.
Invest Ophthalmol Vis Sci. 2024.
PMID: 39636723
Free PMC article.